KKR nears deal to buy Envision Healthcare for USD 5.5 billion
Category: #health  By Dhananjay Punekar  Date: 2018-06-11
  • share
  • Twitter
  • Facebook
  • LinkedIn

KKR nears deal to buy Envision Healthcare for USD 5.5 billion

KKR & Co. L.P., a global investment firm, is reportedly on the verge of signing a purchase deal with Envision Healthcare Corp., one of the largest physician staffing organizations in the U.S. The deal is estimated at USD 5.5 billion, claim sources familiar with the matter.

As per the terms & conditions of the proposed agreement, KKR will pay approximately USD 46 for each of Envision’s share in cash. The price is five percent more than the estimated closing stock price of Envision as displayed on last Friday. In 2017, both these firms had entered a contract, according to which Envision agreed to sell ambulance operations to KKR’s Air Medical Group for nearly USD 2.4 billion.

Reportedly, in May this year, KKR & HCA Healthcare Inc. had made a joint acquisition bid for Envision with an aim to have a competitive advantage over their other business rivals trying to acquire the healthcare firm.

Other firms looking for buying Envision include a group of Carlyle Group LP and TPG, cite sources. Last year, Envision had announced that it was reviewing many strategic options after experiencing disappointing third-quarter earnings. As reported by the NY Times, last year Envision incurred a loss of about USD 228 million, though it had garnered USD 7.8 billion in terms of revenue.

A few weeks back, the U.S. based private equity organization declared to purchase BMC software, a U.S. tech company, from Bain Capital & Golden Gate Capital for USD 8.5 billion. This has been the largest acquisition move made by KKR since 2008, including debt coverage.

Reportedly, 2017 had proved to be a successful year for KKR & Co. L.P., as the company had managed to accrue commendable funding proceeds during the 12-month span. For the record, the private equity organization’s fund closings included a healthcare fund worth USD 1.45 billion and a North America private equity fund worth USD 13.9 billion.



About Author

Dhananjay Punekar

Email: [email protected]   

Dhananjay Punekar

Dhananjay Punekar presently develops content for a slew of portals, including Market Size Forecasters and Algosonline. A post graduate in mathematics and business administration, he worked in Infosys BPO Limited prior to switching his professional genre. As a content wr...

Read More

More News By Dhananjay Punekar

AstraZeneca gets import & marketing approval for Durvalumab in India
AstraZeneca gets import & marketing approval for Durvalumab in India
By Dhananjay Punekar

AstraZeneca Pharma India, a division of pharma & biopharma giant AstraZeneca plc, has received a green signal from the Indian drug regulating agency DCGI (Drug Controller General of India) for its drug Durvalumab c...

BP exits deal with Woolworths, retail firm looks out for alternatives
BP exits deal with Woolworths, retail firm looks out for alternatives
By Dhananjay Punekar

BP Plc, a UK based oil & gas firm, has decided to terminate its USD 1.8 billion acquisition deal with Australian retail giant Woolworths. For the record, the British oil & gas company had signed a pact to purch...

Sarepta obtains positive results on DMD therapy, shares skyrocket 50%
Sarepta obtains positive results on DMD therapy, shares skyrocket 50%
By Dhananjay Punekar

The shares of Sarepta Therapeutics Inc., a medical research & drug development firm, climbed up by 50% after the firm released initial results derived from clinical treatment on patients suffering from Duchenne mus...